equityflowunderstand the flow and follow it
EquityFlow › Companies › Genespire

Genespire

Biotech · Milan, IT

Developer of off-the-shelf gene therapies using immune-shielded lentiviral vectors.

In the network

Shares the most investors with (number = shared investors):
NanoPhoria Bioscience 3

Funding history

DateRoundAmount
Sep 2024Series B
Genespire, a Milan gene-therapy biotech, raised a EUR46.6M Series B co-led by Sofinnova Partners, XGEN Venture and CDP Venture Capital.
$50.3M

Investors

Tap an investor to see what else they have backed.

CDP Venture CapitalIndaco SGRSofinnova PartnersXGEN Venture

Other companies in Biotech

ImperagenHaga BiosciencePixelgen TechnologiesGallantChai DiscoverySNIPR BiomeCellbox LabsScope BiosciencesGenLuminaActitheraNUCLIDIUMAnocca

Other companies in IT

SatispayBending SpoonsWeRoadAIM SolutionsEma HealthWorld4AllSintropy.AIWebidooSibillExeinTodubaSoplaya

Other companies at Series B stage

0x Labs11x.ai1K Kirana1X Technologies1plusX3Commas3SC4baseCare4screen8fig9finACALL
Explore funding flow on EquityFlow →

Data is community-curated and may be incomplete.